<DOC>
	<DOCNO>NCT01134406</DOCNO>
	<brief_summary>The purpose study evaluate safety performance Hydros Joint Therapy ( Hydros ) Hydros-TA Joint Therapy ( Hydros-TA ) treatment pain osteoarthritis knee , patient fail respond adequately conservative non-pharmacologic therapy simple analgesic .</brief_summary>
	<brief_title>Hydros Joint Therapy Hydros-TA Joint Therapy Pain Associated With Knee Osteoarthritis ( OA )</brief_title>
	<detailed_description>The objective study evaluate Hydros Hydros-TA treat subject reduction osteoarthritis symptom , compare commercial control , assess WOMAC Osteoarthritis Index . The WOMAC Osteoarthritis Index validate assessment instrument self-administered design subjectively elicit patient symptom osteoarthritis knee area pain , stiffness , physical function . The WOMAC Osteoarthritis Index Pain Subscale use extensively effectiveness endpoint clinical trial viscosupplements .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Osteoarthritis grade 2 3 one knee use KellgrenLawrence Grading OA radiologically verify within prior 6 month . Secondary OA result rheumatoid arthritis , chondrocalcinosis , osteonecrosis , chronic fibromyalgia autoimmune disease . Generalized symptomatic OA low extremity joint knee . Active infection either knee joint adjacent tissue . Any contraindication intraarticular injection aspiration . Knee surgery trauma within 3 month prior enrollment . Intraarticular steroid injection knee and/or use systemic ( oral ) corticosteroid within 3 month prior enrollment . Intraarticular hyaluronan injection treatment knee within 6 month prior enrollment . Body Mass Index ( BMI ) great 35 .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>knee</keyword>
</DOC>